ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note
k141_20313_20 # 20120 # 22180 # -1 # ID=18_20;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.518	k141_20313_20	20120	22180	-	Strict	300	306.99	poxtA	34.66	3004470	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; tetracycline antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target protection	ABC-F ATP-binding cassette ribosomal protection protein	ATGATTTTATCTTGCAGCAATATTTCAAAAGCATTCGGTACAGAGGAAATCCTCAAACACGTATCGTTTCATGTAGAAGATCACGAAAAAGCCGCCATCGTCGGCATCAACGGAGCCGGTAAATCGACTCTTTTAAAAATAATTGTCGGAGAACTCGCAGCAGACGAGGGCTCCGTGACCATCGCCAAGGGCAAAACCCTCGGTTACCTGGCACAGCACCAGGATCTGCATAGCCAGACCACCATTTATGACTCTCTTCTGGAGGTCAAACGTCCGATTCTGGAAATGGAACAGCAGATCCGCACGCTGGAACTCCAGATGAAGCACGCCGAGGGCGAAAAGCTCGAGACGATGCTCAACACTTACAGCCGCTTAAACCATGAATTTGAACTTTTAAACGGCTACGCATGGCAGAGCGAGATCACCGGTGTCTTAAAGGGACTCGGCTTTGTCGAGGAAGAATTTTCCAAACCGGTTTCCGAACTTTCAGGCGGTCAGAAAACGCGCGTCTCCCTCGGTAAGCTCCTGCTCTCCAAACCGGATATCATCCTTTTGGACGAGCCAACCAACCACCTCGACATGGAATCCATCGCGTGGCTGGAAACCTATCTGATGAACTACGCCGGGACGGTCATTATCGTCGCCCACGACCGCTATTTTCTGGACCGCGTCGTGACCAAGATCGTCGAGCTGGACGGCGGCATCGCCACCTCTTTCCAGGGCAATTACACTGCCTACAGCGAGAAAAAAGCGATCATCCGCGCCGGTGTGCTCAAGGCTTACTTAAACCAACAGCAGGAGATCCGCCATCAGGAGGAGGTTATCAACAAACTCAAATCCTTTAACCGTGAGAAATCCATCAAGCGCGCCGAGAGCCGTGAAAAAATGCTTTCCAAGATGGATCTTCTGGAAAAACCAACCGAAATCAACGACGCGATGCACATTACGCTGGAACCGTGCGTCACCAGCGGAAATGACGTTCTCTCCGTCCGTGAGCTTGCCAAGAGTTTCGACGGCATGACACTCTTCACGGATCTGAACTTTGAGGTAAAACGCGGCGAGCGCATCGCCATCATCGGCAACAACGGAACCGGCAAGACCACAATTCTCAAGATGATCAACGGTCTTCTGACCCCGGACAACGGCGAGATCCGGTTAGGTTCCAAGGTGCATATCGGTTACTACGATCAGGAACACCAGGTTCTGCACATGGACAAGACGCTCTTTGACGAGCTGCAGGACACCTACCCGGATATGAACAACACGCAGATCCGAAATGTGCTGGCGGCATTTCTCTTCACCGGCGACGATGTCTTTAAGCGCATCCGCGATCTGAGCGGCGGCGAACGCGGACGTGTTTCCCTGGCGAAGCTGATGCTCTCGGAGGCGAACTTCCTGATCCTCGATGAGCCGACCAACCATCTGGATATCGCCTCGAAGGAGATTCTGGAAAACGCGCTGGTTCATTATACCGGAACCGTTCTCTACGTCTCCCATGACCGATATTTCATCAACAAAACTGCGACCCGGATTCTCGATCTGACGATGGGAACACTGATTAATTATATTGGAAACTACGATTATTATCTGGAAAAGAAGGAGACGCAGGAGAAAGCCTATCTGGCTTCCGCCGCACAGGCAGCCAGCCGCTCTGCAAAATCTTCCGGAGCCGGAAACACAGGGACTTCCAGTCATCCGACCGCTGCGGCAGGCGCAAATCCGACTGCTCTTTCTGGAAATGGCACTGATACCTCTGCTGCTTCGTCCGCTTCTGCCGTGACCGCTGCAGTTCAGGCGGCAGCCAGCGCTTCCTCTGGCAAATTGGACTGGAAACAACAGAAAGAAGAACAGACGCGGCTTCGTAAGAAACAGAATGAATTGAAACGCGTCGAGGAAGAAATCCACACCCTTGAAACCCGCGATCAGGAGATCGATGCGCTTCTCTGCGATGAGACTGTCTTTTCCGATGTTCCGCGTTTGATGGAACTGAATAAAGAGAAGGAAGAACTGAATGCAAAGTTAGAGGGATTGTATGAGAAGTGGGAGGAATTGGCAGAGTAG	MILSCSNISKAFGTEEILKHVSFHVEDHEKAAIVGINGAGKSTLLKIIVGELAADEGSVTIAKGKTLGYLAQHQDLHSQTTIYDSLLEVKRPILEMEQQIRTLELQMKHAEGEKLETMLNTYSRLNHEFELLNGYAWQSEITGVLKGLGFVEEEFSKPVSELSGGQKTRVSLGKLLLSKPDIILLDEPTNHLDMESIAWLETYLMNYAGTVIIVAHDRYFLDRVVTKIVELDGGIATSFQGNYTAYSEKKAIIRAGVLKAYLNQQQEIRHQEEVINKLKSFNREKSIKRAESREKMLSKMDLLEKPTEINDAMHITLEPCVTSGNDVLSVRELAKSFDGMTLFTDLNFEVKRGERIAIIGNNGTGKTTILKMINGLLTPDNGEIRLGSKVHIGYYDQEHQVLHMDKTLFDELQDTYPDMNNTQIRNVLAAFLFTGDDVFKRIRDLSGGERGRVSLAKLMLSEANFLILDEPTNHLDIASKEILENALVHYTGTVLYVSHDRYFINKTATRILDLTMGTLINYIGNYDYYLEKKETQEKAYLASAAQAASRSAKSSGAGNTGTSSHPTAAAGANPTALSGNGTDTSAASSASAVTAAVQAAASASSGKLDWKQQKEEQTRLRKKQNELKRVEEEIHTLETRDQEIDALLCDETVFSDVPRLMELNKEKEELNAKLEGLYEKWEELAE	MKGKNMNLAFGLEEIYEDAEFQIGDLDKVGIVGVNGAGKTTLFRLLLGELELDNGSLTSGNARIGYLPQEIVLEDEDITVWDFLFEGRPIKKYEQELEEIYKKLETAVNAEQEALLARMGTLQERLEYFDFYEAETILLEFADKMSIDAELYHRPMRELSGGQKSKMAFARLLYSKPEILLLDEPTNHLDVSTKDFVIKYLKNYRGSVLIISHDIDFLNRIINKIMYINKATHKISVYDGDYYIYKKKYAEEQRIREMAIVQQEKEIKELSDFVQKAKQASQTNHHLKRMGQERALRLDKKRGELQKRNRLYKRVKMDIRPKREGAQVPLEVENITFHYSGYPTLYQNLSFQINGRERFLVVGENGVGKSTLLKLMMGILSPDEGCIRFNQKTDIAYYAQELEQLDENKTVIDNVESEGYTPWQIRAVLSNFLFYDDDVNKKVSVLSPGEKARVALCKILLQKANLLILDEPTNHLDPETQKIIGGNFNLFEGTIIAVSHNPSFVEQIGISRMLILPSGRIEPYSRELLEYYYEINGSVAKF	126.57	gnl|BL_ORD_ID|2577|hsp_num:0	2904		
k141_8098_18 # 17118 # 17219 # -1 # ID=48_18;partial=00;start_type=ATG;rbs_motif=AGGA/GGAG/GAGG;rbs_spacer=11-12bp;gc_cont=0.324	k141_8098_18 	17118	17219	-	Strict	500	20.4014	BJP-1	100.0	3000856	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	BJP beta-lactamase	ATGGGGCGGAAAAGATACTGGAAAGAAGAGGCAGAAATAGTTGACGGAATTGCTGTTTATGTAATAGTATTATTATTTAGGAAAGATGAATTATATGTTTGA	MGRKRYWKEEAEIVDGIAVYVIVLLFRKDELYV	MRRLTAALCALTLLSTGAQAQTIKDFLAVAMKKWTAPFEPFQLIDNIYYVGTDGIAVYVIKTSQGLILMDTAMPQSTGMIKDNIAKLGFKVADIKLILNTHAHLDHTGGFAEIKKETGAQLVAGERDKPLLEGGYYPGDEKNEDLAFPAVKVDRAVKEGDRVTLGDTTLTAHATPGHSPGCTSWEMTVKDGKEDREVLFFCSGTVALNRLVGQPTYAGIVDDYRATFAKAKAMKIDVLLGPHPEVYGMQAKRAEMKDGAPNPFIKPGELVTYATSLSEDFDKQLAKQTAALEKK	11.22	gnl|BL_ORD_ID|1970|hsp_num:0	1942	True	loose hit with at least 95 percent identity pushed strict
